Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Laboratory Corporation Of America Holdings (LH)
NYSE:LH
Holding LH?
Track your performance easily
LH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$191.97 - $247.99
Previous Close$226.97
Volume997.15K
Average Volume (3M)581.96K
Market Cap
$18.98B
Enterprise Value$23.79B
Total Cash (Recent Filing)$1.52B
Total Debt (Recent Filing)$6.32B
Price to Earnings (P/E)43.9
Beta0.54
Next Earnings
Feb 06, 2025EPS Estimate
$3.39Last Dividend Ex-Date
Nov 26, 2024Dividend Yield1.27%
Share Statistics
EPS (TTM)5.16
Shares Outstanding83,639,261
10 Day Avg. Volume502,526
30 Day Avg. Volume581,959
Standard Deviation0.09
R-Squared0.40
Alpha-0.00292
Financial Highlights & Ratios
Price to Book (P/B)2.32
Price to Sales (P/S)1.49
Price to Cash Flow (P/CF)17.10
P/FCF Ratio23.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.87
Enterprise Value/Gross Profit7.07
Enterprise Value/Ebitda15.38
Forecast
1Y Price Target
$265.56Price Target Upside16.16% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
Laboratory News
PremiumCompany Announcements
Labcorp Announces New CFO Amid Leadership Transition
Bulls Say, Bears Say
Bulls Say
Earnings And GuidanceGuidance revisions were better than expected, raising by $0.05 excluding the impact of weather.
Financial PerformanceFree cash flow year-to-date totaled approximately +28.1% higher than 2023 ytd figures, a key highlight.
Mergers And AcquisitionsIncremental M&A should support continued share gains, with several recent hospital outreach and local regional lab deals expanding Labcorp's reach in parts of the Southeast and Midwest.
Bears Say
Business Segment PerformanceWeakness in the Early Development business, which represents only 7% of enterprise-level revenues, caused shares to soften post-release.
Financial PerformanceDiagnostics operating margin was down year-over-year due to various headwinds, and margins are expected to be down year-over-year in 2024.
Mergers And AcquisitionsThe Invitae deal surprised the market due to Invitae's historical negative margin profile, with near-term dilution being a concern.
---
Ownership Overview
0.32% Insiders
29.67% Mutual Funds
22.18% Other Institutional Investors
24.15% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
LH FAQ
What was Laboratory Corporation Of America Holdings’s price range in the past 12 months?
Laboratory Corporation Of America Holdings lowest stock price was $191.97 and its highest was $247.99 in the past 12 months.
What is Laboratory Corporation Of America Holdings’s market cap?
Currently, no data Available
When is Laboratory Corporation Of America Holdings’s upcoming earnings report date?
Laboratory Corporation Of America Holdings’s upcoming earnings report date is Feb 06, 2025 which is in 47 days.
How were Laboratory Corporation Of America Holdings’s earnings last quarter?
Laboratory Corporation Of America Holdings released its earnings results on Oct 24, 2024. The company reported $3.5 earnings per share for the quarter, beating the consensus estimate of $3.473 by $0.027.
Is Laboratory Corporation Of America Holdings overvalued?
According to Wall Street analysts Laboratory Corporation Of America Holdings’s price is currently Undervalued.
Does Laboratory Corporation Of America Holdings pay dividends?
Laboratory Corporation Of America Holdings pays a Quarterly dividend of $0.72 which represents an annual dividend yield of 1.27%. See more information on Laboratory Corporation Of America Holdings dividends here
What is Laboratory Corporation Of America Holdings’s EPS estimate?
Laboratory Corporation Of America Holdings’s EPS estimate is $3.39.
How many shares outstanding does Laboratory Corporation Of America Holdings have?
Laboratory Corporation Of America Holdings has 83,639,260 shares outstanding.
What happened to Laboratory Corporation Of America Holdings’s price movement after its last earnings report?
Laboratory Corporation Of America Holdings reported an EPS of $3.5 in its last earnings report, beating expectations of $3.473. Following the earnings report the stock price went up 4.625%.
Which hedge fund is a major shareholder of Laboratory Corporation Of America Holdings?
Among the largest hedge funds holding Laboratory Corporation Of America Holdings’s share is Diamond Hill Capital Management Inc. It holds Laboratory Corporation Of America Holdings’s shares valued at 442M.
---
Laboratory Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$265.56 (16.16% Upside)
$265.56 (16.16% Upside)
Blogger Sentiment
Neutral
LH Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 22.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $4.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▼ 2.7%
Last 30 Days ▼ 2.7%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
2.63%
12-Months-Change
Fundamentals
Return on Equity
5.43%
Trailing 12-Months
Asset Growth
10.22%
Trailing 12-Months
Company Description
Laboratory Corporation Of America Holdings
Laboratory Corp. of America Holdings is a clinical laboratory company, which engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the LabCorp Diagnostics and Covance Drug Development segments. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment involves in providing drug development solutions, to companies in the pharmaceutical and biotechnology industries. The company was founded in 1971 and is headquartered in Burlington, NC.
---
LH Company Deck
---
LH Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected strong financial performance and positive outlooks in various segments, including diagnostics and oncology advancements. However, challenges in early development and margin pressures due to acquisitions and weather presented concerns.Read More>---
LH Revenue Breakdown
77.42% Dx
22.81% BLS
---
LH Stock 12 Month Forecast
Average Price Target
$265.56
▲(16.16% Upside)
Technical Analysis
Best Analysts Covering LH
1 Year
1 Year Success Rate
18/22 ratings generated profit
1 Year Average Return
+13.46%
reiterated a buy rating 4 days ago
Copying Erin Wright's trades and holding each position for 1 Year would result in 81.82% of your transactions generating a profit, with an average return of +13.46% per trade.
---